IP Library Granted Patent US 7,767,436
Granted Patent B2
US 7,767,436 · App. 10/582,887 · Granted Aug 3, 2010

Reducing time to result for blood bank diagnostic testing

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,767,436
App. No.
10/582,887
Granted
Aug 3, 2010
Kind
B2
Abstract

Methods for reducing time to result in blood bank diagnostic testing with an agitation device and a low ionic strength solution are disclosed. Specifically provided are methods for reducing incubation time for antigen-antibody reactions in an immunohematologic assay by subjecting the assay reactants to incubation with agitation and optionally additionally a low ionic strength diluent.

Claims (11)

1. A method for reducing time to result in the form of agglutination in immunohematology assays, comprising:

(a) incubating a sample with antigen positive red blood cells (“RBCs”) admixed with a low ionic strength diluent at 37° C. for from 2 minutes to 15 minutes with continuous agitation;

(b) centrifuging the product of the admixture in step (a) in an anti-IgG matrix for 10 minutes; and

(c) reading the result in the form of agglutination.

2. The method of claim 1 wherein the sample is plasma or serum.

3. The method of claim 1 wherein the continuous agitation is provided by a mechanical agitation block.

4. The method of claim 1 wherein the continuous agitation is provided manually.

5. The method of claim 1 wherein the anti-IgG matrix comprises a gel.

6. The method of claim 1 wherein the anti-IgG matrix comprises glass beads.

7. The method of claim 1 wherein the anti-IgG matrix is disposed in a microtube.

8. The method of claim 1 wherein the diluent has a low ionic strength of less than about 0.03 M.

Assignments (5)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 060219/0571 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
SECURITY INTEREST Recorded Jul 3, 2014
From: ORTHO-CLINICAL DIAGNOSTICS, INC; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 033276/0104 →